◆ 会议时间：2025年9月15-16日
◆ 会议地点：法国 巴黎
◆ 会议简介：
2025年精准肿瘤学分子分析大会(MAP)将于2025年9月15-16日在法国巴黎举行，会议由英国癌症研究所(CRUK)、欧洲肿瘤内科学会(ESMO)和Unicancer联合组织。精准肿瘤学分子分析会议(MAP)是一个领先宣的致力于了解分子进展、有助于使癌症治疗更加个性化的全球性会议，届时来自大型实验室的知名研究人员将展示他们的新数据以及多学科团队将分享其成最新研究成果。未经许可禁止复制转载摘录镜像本站任何内容-国际医学会议网(lingyuint.com)。
MAP 2025 - Molecular Analysis for Precision Oncology Congress 2025
Date:
15 - 16 September 2025
Location:
Maison de la Chimie, Paris, France
The Molecular Analysis for Precision Oncology Congress 2025 will take place from 15 to 16 September in Paris, France, uniting leading experts in oncology, molecular diagnostics, and precision medicine for dynamic discussions and collaboration, with a focus on decoding the molecular bases of cancer to enable precision oncology.
The congress will delve into transformative topics shaping cancer research, including cancer prevention, interception, epigenetics, metastasis, and cancer evolution, offering a deeper understanding of mechanisms driving progression and resistance.
Attendees will explore the impact of artificial intelligence in revolutionising diagnostics, therapeutics, and outcomes, alongside advancements in cancer immunology and the next generation of immunotherapies.
Key themes will include aging and senescence, microbiome insights bridging basic research to clinical applications, and metabolism dysregulation, focusing on therapeutic vulnerabilities in cancer cells to foster innovative treatments.
Organised through a partnership between Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO), and Unicancer, MAP 2025 promises a cutting-edge programme at the forefront of cancer research and care.
Join us in Paris to shape the future of oncology through science, medicine, and innovation.
Scientific Co-Chairs
Lisa Derosa
Villejuif, France (Unicancer)
Mariam Jamal-Hanjani
London, UK (CRUK)
Joaquin Mateo
Barcelona, Spain (ESMO)
摘要征文投稿：
| Deadline |
Date and time |
| Abstracts |
10 June 2025, 21:00hrs CEST
(CEST = Central European Summer Time) |
Abstract submission categories
- Artificial intelligence (AI)
- Biomarkers (prognostic and predictive)
- Cancer cell biology
- Clinical practice
- Multiomics and molecular characterisation of cancers
- New therapies and clinical trials
- Tumour microenvironment
- Miscellaneous
Outcome notifications
Outcome notifications are expected to be made available to first authors and submitters by early July.
Information for presenters
Detailed instructions for the preparation of slide presentations and/or posters will be made available by early July in the section “Information for Presenters”.
Abstract presenter registration
The presenting author or the designated replacement presenter must be registered by 27 August 2025. Should the Presenter (or designated replacement presenter) not be registered by the given deadline, the abstract will be excluded from presentation in the MAP Congress 2025 programme, and removed from the online programme and publication in the MAP Congress 2025 Abstract Book.
Presentation and publication of accepted abstracts
The Molecular Analysis for Precision Oncology Congress 2025 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Paper poster presentation for review and discussion onsite. Presenting authors must attend the Congress in person to represent their work. Preparation of an ePoster is also mandatory for inclusion in the ePoster Gallery.
- E-Poster – Electronic poster in PDF format for inclusion in the ePoster Gallery. Presenting authors of ePosters are not required to attend the Congress in person to represent their work. Paper posters are not to be prepared, and poster boards will not be provided.
All accepted abstracts will be published online only in the Molecular Analysis for Precision Oncology Congress 2025 Abstract Book, a supplement to the official ESMO journal, ESMO Open.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
